CALY
Callaway Golf Company
CALY offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
NKE
NIKE, Inc.
NKE has the edge over CALY overall, supported by stronger valuation and lower modeled downside.
CALY Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Stable | |
| Strong | |
| Strong |
CALY's cash flow and balance sheet are currently strong, and its profitability is stable, but its revenue is weak.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
CALY PE Valuation
CALY has no meaningful PE right now: it lost money over the past year.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE's PE is in its cheap range at 18x. On analysts' estimates for next year's earnings, today's price would be 30x, in its fair range.
CALY Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Decline | |
| Strongly improving | |
| Limited | |
| Low |
CALY has the edge over NKE on the outlook, with more favorable earnings expectations.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
CALY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.98 | — |
| Q3 2026 | -$1.15 | +$7.03 |
| Q2 2026 | -$1.48 | +$6.64 |
| Q1 2026 | -$1.77 | +$6.14 |
| Q4 2025 | -$2.23 | +$5.65 |
| Q3 2025 | -$8.18 | -$8.14 |
| Q2 2025 | -$8.12 | -5900% |
| Q1 2025 | -$7.91 | -2029% |
| Q4 2024 | -$7.88 | -1676% |
CALY is still losing money, but far less than before: $1.15 per share over the past year, against $8.18 at its worst in late 2025.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE has the edge over CALY on earnings quality, reporting a profit while its opponent remains loss making.
CALY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $436.9M | -53% |
| Q2 2026 | $612.2M | -45% |
| Q1 2026 | $687.5M | -37% |
| Q4 2025 | $367.5M | -60% |
| Q3 2025 | $934M | -7.8% |
| Q2 2025 | $1.1B | -4.1% |
| Q1 2025 | $1.1B | -4.5% |
| Q4 2024 | $924.4M | +3% |
CALY's revenue has slid since its 2023 peak: $437M last quarter, down 53% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 10% | +7.2 points |
| Q2 2026 | 19% | +9.2 points |
| Q1 2026 | 20% | +14 points |
| Q4 2025 | -15% | +143 points |
| Q3 2025 | 3% | -0.3 points |
| Q2 2025 | 9.5% | +0.6 points |
| Q1 2025 | 6.1% | +0.2 points |
| Q4 2024 | -158% | -154 points |
CALY has the edge over NKE on profitability, with a higher operating margin.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE has the edge over CALY on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE's operating margin was 8.2% last quarter, about level with the same quarter a year ago.
CALY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $180.8M | +12% |
| Q2 2026 | $238.1M | +354% |
| Q1 2026 | -$176M | -$20.9M |
| Q4 2025 | $242.7M | +$267.7M |
| Q3 2025 | $162.1M | +48% |
| Q2 2025 | $52.5M | -63% |
| Q1 2025 | -$155.1M | -$16.4M |
| Q4 2024 | -$25M | -157% |
CALY has the edge over NKE on cash flow, with more consistent year-over-year improvement.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE usually generates cash, though not every quarter: the latest was −$64M, but it generated $2.1B over the past year.
CALY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3.6% | -6.8M shares |
| 1 year | -0.3% | -600K shares |
| 3 years | -8.9% | -17.9M shares |
| 5 years | -1.4% | -2.7M shares |
| Available history | +90% | +87M shares |
CALY has the edge over NKE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $50.7M |
| Q2 2026 | $42.5M |
| Q1 2026 | $42M |
| Q4 2025 | $300,000 |
| Q3 2025 | $100,000 |
| Q2 2025 | — |
| Q1 2025 | $3.3M |
| Q4 2024 | — |
CALY spent $136M buying back its own shares over the past year, more than ten times what it spent the year before.
NKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.4% | +5.2M shares |
| 3 years | -3.8% | -59.1M shares |
| 5 years | -8.4% | -135M shares |
| Available history | -6.9% | -110M shares |
NKE has 1.5B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $20M |
| Q3 2025 | $126M |
| Q2 2025 | $199M |
| Q1 2025 | $506M |
| Q4 2024 | $1.1B |
NKE has spent almost nothing on buybacks in the past year.
CALY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -3.2x | Net Cash |
| Q2 2026 | -1.5x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | 2.9x | Moderate |
| Q3 2024 | 2.5x | Moderate |
| Q2 2024 | 2.6x | Moderate |
| Q1 2024 | 2.9x | Moderate |
| Q4 2023 | 2.5x | Moderate |
CALY has the edge over NKE on leverage, with a lower net debt burden relative to earnings.
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE's net debt is less than a year of its operating earnings (EBITDA).
CALY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.0 | Neutral |
| Stochastic | 51.0 | Neutral |
CALY's weekly RSI is 56 (neutral) and its Stochastic is 51 (neutral).
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
CALY PE vs Consumer Cyclical Sector
| Metric | CALY | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
CALY has no meaningful PE right now: it lost money over the past year.
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x.
CALY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $14.9 | 11% above |
| 20 week MA | $16.2 | 2.5% above |
| 50 week MA | $15.1 | 9.5% above |
| 100 week MA | $11.7 | 42% above |
| 200 week MA | $13.6 | 22% above |
CALY has the edge over NKE on trend strength, trading above more of its moving averages.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 52% below its 200-week average.
CALY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $20.9 | $24.4 | +17% |
| 2021 | $24.4 | $27.0 | +11% |
| 2022 | $27.0 | $19.7 | -27% |
| 2023 | $19.7 | $14.3 | -27% |
| 2024 | $14.3 | $7.72 | -46% |
| 2025 | $7.72 | $11.7 | +52% |
| 2026 YTD | $11.7 | $16.6 | +41% |
CALY has the edge over NKE on returns for 2026, with the stronger performance.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has finished four years in a row lower, and it's down 38% so far in 2026.